Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Falkenburg

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Blood|February 1, 1988
Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factorW E Fibbe, J van Damme, A Billiau, et al.
Blood|May 30, 1998
Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemiaH C Kluin-Nelemans, M G Kester, L van deCorput, et al.
Experimental Hematology|September 18, 1997
Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemiaJ F de Kroon, H C Kluin-Nelemans, P M Kluin, et al.
The New England Journal of Medicine|February 1, 1996
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantationE Goulmy, R Schipper, J Pool, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantationJ H Falkenburg, L M Faber, M van den Elshout, et al.
Annals of Hematology|February 1, 1995
High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphomaR Willemze, J M Zijlmans, G J den Ottolander, et al.
Annals of Hematology|February 1, 1991
Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemiaR Willemze, W E Fibbe, J C Kluin-Nelemans, et al.
Bone Marrow Transplantation|August 18, 2001
Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sourcesW A Noort, J Wilpshaar, C D Hertogh, et al.
Leukemia|May 10, 2000
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant RegistryE F Posthuma, J H Falkenburg, J F Apperley, et al.
Experimental Hematology|July 1, 1996
Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid miceJ F de Kroon, R A de Paus, H C Kluin-Nelemans, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Blood|February 1, 1988
Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factorW E Fibbe, J van Damme, A Billiau, et al.
Blood|May 30, 1998
Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemiaH C Kluin-Nelemans, M G Kester, L van deCorput, et al.
Experimental Hematology|September 18, 1997
Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemiaJ F de Kroon, H C Kluin-Nelemans, P M Kluin, et al.
The New England Journal of Medicine|February 1, 1996
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantationE Goulmy, R Schipper, J Pool, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantationJ H Falkenburg, L M Faber, M van den Elshout, et al.
Annals of Hematology|February 1, 1995
High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphomaR Willemze, J M Zijlmans, G J den Ottolander, et al.
Annals of Hematology|February 1, 1991
Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemiaR Willemze, W E Fibbe, J C Kluin-Nelemans, et al.
Bone Marrow Transplantation|August 18, 2001
Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sourcesW A Noort, J Wilpshaar, C D Hertogh, et al.
Leukemia|May 10, 2000
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant RegistryE F Posthuma, J H Falkenburg, J F Apperley, et al.
Experimental Hematology|July 1, 1996
Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid miceJ F de Kroon, R A de Paus, H C Kluin-Nelemans, et al.
Pageof 11